Scynexis (SCYX) Selling, General & Administrative (2013 - 2026)
Scynexis (SCYX) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Scynexis | 61.25 Mn | -53.45 Mn | - | 4.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.12 Mn |
| Mar 31, 2026 | 4.59 Mn |
| Dec 31, 2025 | 3.58 Mn |
| Sep 30, 2025 | 3.29 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 4.72 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 3.17 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Dec 31, 2023 | 3.59 Mn |
| Sep 30, 2023 | 5.01 Mn |
| Jun 30, 2023 | 7.47 Mn |
| Mar 31, 2023 | 4.84 Mn |
| Dec 31, 2022 | 15.96 Mn |
| Sep 30, 2022 | 16.74 Mn |
| Jun 30, 2022 | 15.79 Mn |
| Mar 31, 2022 | 14.59 Mn |
| Dec 31, 2021 | 15.04 Mn |
| Sep 30, 2021 | 15.41 Mn |